WallStreetZenWallStreetZen

NASDAQ: TGTX
Tg Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for TGTX

Based on 5 analysts offering 12 month price targets for Tg Therapeutics Inc.
Min Forecast
$13.00-5.66%
Avg Forecast
$30.20+119.16%
Max Forecast
$45.00+226.56%

Should I buy or sell TGTX stock?

Based on 5 analysts offering ratings for Tg Therapeutics Inc.
Strong Buy
Strong Buy
3 analysts 60%
Buy
1 analysts 20%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TGTX stock forecasts and price targets.

TGTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-18
lockedlocked$00.00+00.00%2024-04-18
lockedlocked$00.00+00.00%2024-04-18
lockedlocked$00.00+00.00%2024-02-29
lockedlocked$00.00+00.00%2024-02-05Find Out Why

1 of 1

Forecast return on equity

Is TGTX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36%

Forecast return on assets

Is TGTX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

TGTX revenue forecast

What is TGTX's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$254.8M+9.05%
Avg 2 year Forecast
$415.2M+77.7%
Avg 3 year Forecast
$628.8M+169.09%
TGTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TGTX earnings growth forecast

How is TGTX forecast to perform vs Biotechnology companies and vs the US market?
Company
139.09%
Industry
7.34%
Market
21.89%
TGTX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
TGTX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
TGTX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

TGTX revenue growth forecast

How is TGTX forecast to perform vs Biotechnology companies and vs the US market?
Company
38.43%
Industry
38.03%
Market
10.06%
TGTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TGTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TGTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TGTX$13.78$30.20+119.16%Strong Buy
CLDX$37.98$66.00+73.78%Strong Buy
VCEL$43.74$53.50+22.31%Strong Buy
KROS$58.28$90.20+54.77%Strong Buy
KYMR$33.97$40.25+18.49%Buy
View Top Biotech Stocks

Tg Therapeutics Stock Forecast FAQ

Is Tg Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: TGTX) stock is to Strong Buy TGTX stock.

Out of 5 analysts, 3 (60%) are recommending TGTX as a Strong Buy, 1 (20%) are recommending TGTX as a Buy, 1 (20%) are recommending TGTX as a Hold, 0 (0%) are recommending TGTX as a Sell, and 0 (0%) are recommending TGTX as a Strong Sell.

If you're new to stock investing, here's how to buy Tg Therapeutics stock.

What is TGTX's revenue growth forecast for 2024-2026?

(NASDAQ: TGTX) Tg Therapeutics's forecast annual revenue growth rate of 38.43% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.03%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.06%.

Tg Therapeutics's revenue in 2024 is $233,662,000.On average, 4 Wall Street analysts forecast TGTX's revenue for 2024 to be $39,346,412,706, with the lowest TGTX revenue forecast at $37,023,924,295, and the highest TGTX revenue forecast at $42,373,059,837. On average, 4 Wall Street analysts forecast TGTX's revenue for 2025 to be $64,119,673,895, with the lowest TGTX revenue forecast at $50,483,238,782, and the highest TGTX revenue forecast at $83,433,543,112.

In 2026, TGTX is forecast to generate $97,092,832,499 in revenue, with the lowest revenue forecast at $63,107,136,893 and the highest revenue forecast at $122,764,513,740.

What is TGTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: TGTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is TGTX's Price Target?

According to 5 Wall Street analysts that have issued a 1 year TGTX price target, the average TGTX price target is $30.20, with the highest TGTX stock price forecast at $45.00 and the lowest TGTX stock price forecast at $13.00.

On average, Wall Street analysts predict that Tg Therapeutics's share price could reach $30.20 by Apr 18, 2025. The average Tg Therapeutics stock price prediction forecasts a potential upside of 119.16% from the current TGTX share price of $13.78.

What is TGTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: TGTX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.